The Primary
Care Companionfor CNS Disorders

Neurology Dementia

Letter to the Editor December 15, 2008

Risperidone- and Aripiprazole-Induced Leukopenia: A Case Report

Salah Uddin Qureshi, M.D.; Eleonora Rubin, M.D.

Prim Care Companion J Clin Psychiatry 2008;10(6):482-483

Article Abstract

Letter to the Editor

Risperidone- and Aripiprazole-Induced Leukopenia: A Case Report

About the Authors

Download Free PDF

This PDF is free for all visitors!

Save

Cite

Sponsored

PsychCase360: Choosing the Right Long-Acting Injectable for Patients With Schizophrenia

Explore two real-world schizophrenia cases with Roueen Rafeyan, MD and Melissa Vitale, PMHNP as they discuss challenges with medication adherence, transitioning to long-acting injectables (LAIs), and personalizing treatment strategies to improve patient outcomes.

Vol 27 • 2025 • Number 4

Read the Current Issue

Letter to the Editor

Knowledge of ECT for Catatonia

Original Research

Predictors of Depression Response in a Community ECT Clinic

Original Research

Medical Student Reactions to Interviewing Psychiatric Inpatients

Review Article

Climate Change and Mental Health

Rounds in the General Hospital

Management of Functional Neurological Disorder

Rounds in the General Hospital

PTSD Management in Primary Care

View current Issue

Related Articles

Why Ask Patients to Cut Into Quarters 10 mg THC Gummies From a Dispensary When 2.5 mg THC Is Available by Prescription?

Letter to the Editor

Why Ask Patients to Cut Into Quarters 10 mg THC Gummies From a Dispensary When 2.5 mg THC Is Available by Prescription?

June 5, 2024

The authors discuss a study by Sawicki et al of dementia patients for whom 2.5 mg of THC was recommended for neuropsychiatric symptoms.

Marina Goldman, Dimitri Markov

THC Edible Gummies for Behavioral Symptoms of Dementia: Reply to Goldman and Markov

Letter to the Editor

THC Edible Gummies for Behavioral Symptoms of Dementia: Reply to Goldman and Markov

June 5, 2024

The authors reply to Goldman and Markov’s comments on their recent study of dispensary-obtained THC for dementia.

Erin K. Zahradnik, Cristian Hernandez

Insights Into Poststroke Depression

Letter to the Editor

Insights Into Poststroke Depression

August 31, 2023

The authors shed light on risk factors, purported mechanisms, diagnostic tips, and treatment options for poststroke depression.

Ahmed Naguy, Bibi Alamiri